BIOPHTA

BIOPHTA is dedicated to changing the lives of patients suffering from chronic eye diseases through innovative pharmaceutical solutions. Focusing on the critical unmet medical need of adherence to prescription eye drops, BIOPHTA is developing a best-in-class solution to reduce the burden of treatments and improve patient outcomes.

Located at BIOLABS campus Broussais, 8, rue Maria Helena Vieira Da Silva, Paris, 75014, FR, BIOPHTA is pioneering a novel pharmaceutical platform that enables continuous drug delivery. Their topical Mucoadhesive Ocular Hydrogel Insert releases drugs on the eye for a one-week period, enhancing the efficacy and potency of medications. These non-invasive topical ocular inserts are designed to provide better long-term control of various ophthalmic indications.

BIOPHTA’s innovative approach aims to improve patient adherence to treatment regimens, reduce the frequency and complexity of eye drop applications, and generate a continuous and controlled sustained release of medication. BIOPHTA is committed to advancing the field of ophthalmology and improving the quality of life for patients worldwide. We invite the manager of BIOPHTA to create a customized and exclusive company showcase and product listing on our platform.